CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-20 | Schafer Klaus Director | Option exercise | +60 | $2.40 | $144 | 8,960 |
| 2022-06-20 | Schafer Klaus Director | Option exercise | +159 | $2.40 | $382 | 9,119 |
| 2022-06-20 | Schafer Klaus Director | Option exercise | +60 | $2.40 | $144 | 9,179 |
| 2022-06-20 | Schafer Klaus Director | Option exercise · Stock Options (option to buy) | −60 | 0 | ||
| 2022-06-20 | Schafer Klaus Director | Option exercise · Stock Options (option to buy) | −159 | 0 | ||
| 2022-06-20 | Schafer Klaus Director | Option exercise · Stock Options (option to buy) | −60 | 0 | ||
| 2022-06-15 | Drutz David Director | Purchase | +1,000 | $8.00 | $8K | 20,012 |
| 2022-05-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −3,008 | $5.03 | $15K | 280,818 |
| 2022-05-24 | Drutz David Director | Purchase | +1,200 | $4.50 | $5K | 19,012 |
| 2022-04-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −3,008 | $4.52 | $14K | 283,826 |
| 2022-03-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −3,007 | $6.05 | $18K | 286,834 |
| 2022-02-28 | Harris Matthew Scott Chief Medical Officer | Option exercise | +30,000 | $1.92 | $58K | 41,545 |
| 2022-02-28 | Harris Matthew Scott Chief Medical Officer | Sale | −30,000 | $7.52 | $226K | 11,545 |
| 2022-02-28 | Harris Matthew Scott Chief Medical Officer | Option exercise · Stock Options (option to buy) | −30,000 | 31,400 | ||
| 2022-02-28 | Garg Vipin K President and CEO | Shares withheld for taxes | −3,007 | $7.41 | $22K | 289,841 |
| 2022-02-02 | Harris Matthew Scott Chief Medical Officer | Grant or award · Stock Options (option to buy) | +91,600 | 91,600 | ||
| 2022-02-02 | Harris Matthew Scott Chief Medical Officer | Grant or award · Restricted Stock Units | +31,100 | 31,100 | ||
| 2022-02-02 | Garg Vipin K President and CEO | Grant or award · Stock Options (option to buy) | +223,000 | 223,000 | ||
| 2022-02-02 | Garg Vipin K President and CEO | Grant or award · Restricted Stock Units | +75,800 | 75,800 | ||
| 2022-02-02 | Roberts M Scot Chief Scientific Officer | Grant or award · Stock Options (option to buy) | +91,600 | 91,600 |
Page 17 of 29 · 568 trades